{"transactions":[{"id":1938367,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-27T21:28:43.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-23-021260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021260/doc4.xml","form_type":"4"}},{"id":1938366,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-27T21:28:43.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":50000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-23-021260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021260/doc4.xml","form_type":"4"}},{"id":2205750,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-19T20:37:54.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":9900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9900,"derivative":{"underlying":"Common Stock","underlying_shares":9900},"source":{"system":"sec-edgar","filing":"0001209191-22-042572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042572/doc4.xml","form_type":"4"}},{"id":2205749,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T20:37:54.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":59400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":59400,"derivative":{"exercise_price":4.01,"expiration_date":"2032-07-15","underlying":"Common Stock","underlying_shares":59400},"source":{"system":"sec-edgar","filing":"0001209191-22-042572","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042572/doc4.xml","form_type":"4"}},{"id":2260741,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-05-23T20:00:47.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":3000,"price":2.7,"value":8100.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-22-005491","document":"form4a-05232022_040535.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005491/form4a-05232022_040535.xml","form_type":"4/A","original_submission_date":"2022-05-19"}},{"id":2264511,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":115154,"kind":"person","name":"Calabrese Salvatore","position":1,"cik":"0001851958","reported_name":"Calabrese Salvatore","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2022-05-19T21:00:20.000Z","date":"2022-05-19","kind":"purchase","acquired":true,"shares":3000,"price":8100,"value":24300000.0,"ownership":{"direct":true},"source":{"system":"sec-edgar","filing":"0001415889-22-005317","document":"form4-05192022_050501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588922005317/form4-05192022_050501.xml","form_type":"4"}}]}